e-learning
resources
Virtual 2020
Pre-Congress Content
COPD and the impact of comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Silent exacerbations: underreporting of COPD exacerbations in Poland
M. Farnik (Katowice, Poland), D. Brzostek (Warszawa, Poland)
Source:
Virtual Congress 2020 – COPD and the impact of comorbidities
Session:
COPD and the impact of comorbidities
Session type:
E-poster session
Number:
2467
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Farnik (Katowice, Poland), D. Brzostek (Warszawa, Poland). Late Breaking Abstract - Silent exacerbations: underreporting of COPD exacerbations in Poland. 2467
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Late Breaking Abstract - The socio-economic cost of asthma, COPD and chronic bronchitis in Europe.
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD
Source: International Congress 2017 – Late-breaking studies in asthma and COPD
Year: 2017
Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: Fact or fiction?
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
COPD exacerbations: Causes and consequences
Source: ERS Live 2007
Year: 2007
Late Breaking Abstract - Estimating the relationship between environmental exposures and acute exacerbations of COPD
Source: Virtual Congress 2021 – Occupational COVID-19 and respiratory infections
Year: 2021
Late Breaking Abstract - Impact of COPD symptom-related attacks on quality of life and exacerbations
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
Late Breaking Abstract - Azithromycin for acute COPD exacerbations requiring hospitalization – the BACE trial results
Source: International Congress 2018 – Clinical trials in COPD: new results
Year: 2018
Late Breaking Abstract - Diagnosis of chronic obstructive pulmonary disease (COPD) exacerbations using a smartphone-based, cough-centred algorithm
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Late Breaking Abstract - Air pollution and IPF acute exacerbation
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
Etiological structure from sputum of patients with exacerbation of COPD
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Infective exacerbations of COPD. Relation between the bacteriologic etiology and severity of the disease
Source: International Congress 2014 – COPD markers
Year: 2014
Pneumonia or exacerbation of COPD?
Source: Eur Respir Monogr 2015; 69: 185-196
Year: 2015
Acute exacerbation of COPD in Emergency Room: just COPD exacerbations?
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014
Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Management of acute COPD exacerbations in Australia: do we follow the guidelines?
Source: ERJ Open Res, 6 (2) 00270-2019; 10.1183/23120541.00270-2019
Year: 2020
Late Breaking Abstract - Indacaterol/glycopyrronium versus salmeterol/fluticasone in chronic obstructive pulmonary disease: a meta-analysis on the protection against the risk of exacerbation
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
COPD exacerbation admissions: Analysis of demographics and mortality
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease?
Source: International Congress 2014 – Comorbidities
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept